Company Analysis

Silexion Therapeutics Corp (SLXN)

Nasdaq: SLXN · Biological Products, (No Diagnostic Substances) · Ramat Gan, IL · filing with the SEC since 2024
Grade4.3
◀ Past 2.3● Present 2.7▶ Future 6.8
3 est.

Filings

254 filings since 2017 beside 29 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026
Due next and emerging growth company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Oct 5, 2026.

Filings a yearinsider forms included
7012192
202420252026

2026 counts to Nov 13, 2026.

Listing warning from its exchange (8-K item 3.01): 6 times in the last 36 months, the newest Sep 25, 2026.Officer or director change (8-K item 5.02): 5 times in the last 36 months, the newest Jul 31, 2026.SEC letters: 24 in the last 36 months, the newest Jun 16, 2026.
Insider forms 29

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 10-Q Quarterly report Sep 30, 2026
Nov 12, 2026 8-K items 3.03, 5.03, 8.01, 9.01 Change to shareholders' rights; Charter, bylaw or fiscal-year change; Other event · Current report
Nov 9, 2026 EFFECT Registration effective
Nov 9, 2026 8-K items 8.01, 9.01 Other event · Current report
Oct 28, 2026 S-3 Shelf registration
Oct 26, 2026 8-K items 5.03, 5.07, 9.01 Charter, bylaw or fiscal-year change; Shareholder vote · Current report
Oct 19, 2026 DEFA14A Extra proxy material
Oct 5, 2026 DEF 14A Proxy statement
Sep 30, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Sep 29, 2026 424B3 Shelf offering
Sep 29, 2026 8-K items 1.01, 3.02, 8.01, 9.01 Major agreement signed; Shares sold without registration; Other event · Current report Sep 28, 2026
Sep 28, 2026 SCHEDULE 13D/A Activist holder update, amended
Sep 28, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Sep 25, 2026 8-K item 3.01 Listing warning from its exchange · Current report
Sep 25, 2026 PRE 14A Preliminary proxy statement
Sep 25, 2026 8-K item 5.07 Shareholder vote · Current report
Sep 16, 2026 DEFA14A Extra proxy material
Sep 9, 2026 DEFA14A Extra proxy material
Aug 24, 2026 DEF 14A Proxy statement
Aug 21, 2026 8-K item 3.01 Listing warning from its exchange · Current report
Aug 19, 2026 SCHEDULE 13D/A Activist holder update, amended
Aug 18, 2026 SCHEDULE 13G Large holder notice
Aug 14, 2026 PRE 14A Preliminary proxy statement
Aug 14, 2026 10-Q Quarterly report Jun 30, 2026
Aug 14, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 13, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 13, 2026 8-K items 8.01, 9.01 Other event · Current report
Aug 13, 2026 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report
Aug 13, 2026 424B4 Offering prospectus
Aug 11, 2026 EFFECT Registration effective
Aug 10, 2026 S-1/A Listing registration, amended
Aug 10, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 7, 2026 S-1 Listing registration
Aug 4, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 3, 2026 8-K item 8.01 Other event · Current report
Jul 31, 2026 8-K item 5.02 Officer or director change · Current report
Jul 29, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jul 21, 2026 8-K items 5.03, 5.07, 9.01 Charter, bylaw or fiscal-year change; Shareholder vote · Current report
Jul 13, 2026 DEFA14A Extra proxy material
Jun 23, 2026 SCHEDULE 13D/A Activist holder update, amended
40 of 254 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton SLXN · research, not advice